MIB Agents Family Funds support research through our annual OutSmarting Osteosarcoma research grant program. Since launching in 2017, MIB Agents Family Funds have awarded $2.5 million in osteosarcoma research funding, supporting 32 investigators. In 2022, we introduced a dedicated Young Investigator Grant, and since then, we’re proud to have supported 14 early-career scientists driving progress in the field.
SEE FUNDED RESEARCHLaunched in 2017 and powered by MIB Agents Family Funds, the OutSmarting Osteosarcoma Research Grant has fueled discovery by awarding $2.5 million to 32 dedicated investigators working to advance osteosarcoma research. But the impact of this investment extends far beyond these studies. As a result of OutSmarting Osteosarcoma's investment, MIB Agents funded studies have resulted in:
.png)
159 Presentations sharing findings with the scientific community
.png)
19 Publications disseminating findings into the public domain
.png)
7 clinical trials opened
.png)
$21.1 million secured in additional osteosarcoma research funding
